REGIONAL HEMODYNAMIC-EFFECTS OF MU-OPIOID, DELTA-OPIOID, AND KAPPA-OPIOID AGONISTS MICROINJECTED INTO THE HYPOTHALAMIC PARAVENTRICULAR NUCLEI OF CONSCIOUS, UNRESTRAINED RATS

1 The cardiovascular effects of bilateral injection into the hypothalamic paraventricular nuclei of selective mu-, delta-, and kappa-opioid receptor agonists were investigated in conscious, unrestrained Wistar Kyoto rats, chronically instrumented with pulsed Doppler flow probes for measurement of regional haemodynamics. 2 The selective mu-agonist [D-Ala(2),MePhe(4),Gly(5)ol]enkephalin (DAMGO), injected bilaterally into the hypothalamic paraventricular nuclei (0.01-1.0 nmol), caused increases in blood pressure, tachycardias, vasoconstriction in renal and superior mesenteric vascular beds and substantial vasodilatation in the hindquarter vascular bed. 3 The administration of increasing doses (0.01-5.0 nmol) of the selective delta-agonist [D-Phe(2,5)]enkephalin (DPDPE) or the selective kappa-agonist, U50488H into the paraventricular nuclei (PVN) had no significant effect on blood pressure, heart rate, or regional haemodynamics. 4 Together, the present results are further evidence of a role for opioid peptides, especially acting at mu-receptors in the PVN, in the central regulation of the cardiovascular system, whereas a role for opioid peptides, acting at delta- and kappa-receptors in the PVN, seems less obvious from the present results.